Captrust Financial Advisors Atri Cure, Inc. Transaction History
Captrust Financial Advisors
- $33 Billion
- Q3 2024
A detailed history of Captrust Financial Advisors transactions in Atri Cure, Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 8,191 shares of ATRC stock, worth $332,390. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,191Holding current value
$332,390% of portfolio
0.0%Shares
17 transactions
Others Institutions Holding ATRC
# of Institutions
213Shares Held
49.6MCall Options Held
12KPut Options Held
7.2K-
Vanguard Group Inc Valley Forge, PA4.66MShares$189 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$187 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.97MShares$161 Million0.04% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL2.83MShares$115 Million1.47% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.79MShares$113 Million0.5% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.88B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...